Navigating pyruvate kinase deficiency today: How can the disease burden and unmet treatment needs be addressed?

touchPANEL DISCUSSION for touchONCOLOGY 

Listen to a panel of leading experts discuss the burden and clinical presentation of pyruvate kinase (PK) deficiency, the current treatment strategies and remaining unmet treatment need, and future approaches to managing the disease. 

The experts

• Dr Rachael Grace, Dana-Farber/Boston Children’s Cancer and Blood Disorders Center and Harvard Medical School, Boston, MA, USA
• Dr Hanny Al-Samkari, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA
• Prof. Ami J Shah, Lucile Packard Children’s Hospital Stanford, and Stanford University, Palo Alto, CA, USA

This touchPODCAST is for HCPs only. 

This activity is funded by an independent medical education grant from Agios Pharmaceuticals and is jointly provided by USF Health and touchIME. 

For further information visit: TBC